NEW YORK, Aug. 11 (GenomeWeb News) - Neurome plans to buy "substantially all" the assets owned by Digital Gene Technologies, including its gene-expression assays and gene-expression-analysis platform called TOGA, the companies said yesterday.
Neurome, which develops databases that depict and integrate gene-expression patterns of the brain, will also acquire DGT's entire patent estate. This includes data and discoveries generated in commercial and academic research programs.
Terms of the acquisition were not disclosed.
Neurome and DGT are both based in